International Consensus on Use of Continuous Glucose Monitoring.

International Consensus on Use of Continuous Glucose Monitoring.
复制标题

DOI:
10.2337/dc17-1600
复制
发表时间:
2017-12
期刊:
影响因子:
16.2
通讯作者:
Phillip M
Phillip M
中科院分区:
医学1区
文献类型:
--
作者:
Danne T;Nimri R;Battelino T;Bergenstal RM;Close KL;DeVries JH;Garg S;Heinemann L;Hirsch I;Amiel SA;Beck R;Bosi E;Buckingham B;Cobelli C;Dassau E;Doyle FJ 3rd;Heller S;Hovorka R;Jia W;Jones T;Kordonouri O;Kovatchev B;Kowalski A;Laffel L;Maahs D;Murphy HR;Nørgaard K;Parkin CG;Renard E;Saboo B;Scharf M;Tamborlane WV;Weinzimer SA;Phillip M

文献摘要

参考文献

被引文献

相似文献

糖化血红蛋白(HbA1c)的测量一直是评估血糖控制的传统方法。然而,它并不反映可能导致急性事件(如低血糖)或餐后高血糖的日内和日间血糖波动,这些事件与微血管和大血管并发症有关。动态血糖监测(CGM),无论是实时使用(rtCGM)还是间歇观察(iCGM),都解决了HbA1c检测和血糖自我监测中固有的许多局限性。虽然两者都提供了超越HbA1c测量作为血糖控制唯一标志的方法,但缺乏用于分析CGM数据的标准化指标。此外,将糖尿病患者与最合适的血糖监测方法相匹配的明确标准,以及如何最好地使用它们提供的新信息的标准化建议,尚未建立。2017年2月,糖尿病先进技术与治疗(ATTD)大会召集了一个由CGM技术专家组成的国际专家组,由医生、研究人员和糖尿病患者组成,以解决这些问题。本文总结了ATTD共识建议,并代表了目前对CGM结果如何影响结局的理解。
Measurement of glycated hemoglobin (HbA1c) has been the traditional method for assessing glycemic control. However, it does not reflect intra- and interday glycemic excursions that may lead to acute events (such as hypoglycemia) or postprandial hyperglycemia, which have been linked to both microvascular and macrovascular complications. Continuous glucose monitoring (CGM), either from real-time use (rtCGM) or intermittently viewed (iCGM), addresses many of the limitations inherent in HbA1c testing and self-monitoring of blood glucose. Although both provide the means to move beyond the HbA1c measurement as the sole marker of glycemic control, standardized metrics for analyzing CGM data are lacking. Moreover, clear criteria for matching people with diabetes to the most appropriate glucose monitoring methodologies, as well as standardized advice about how best to use the new information they provide, have yet to be established. In February 2017, the Advanced Technologies & Treatments for Diabetes (ATTD) Congress convened an international panel of physicians, researchers, and individuals with diabetes who are expert in CGM technologies to address these issues. This article summarizes the ATTD consensus recommendations and represents the current understanding of how CGM results can affect outcomes.
DOI: 10.7326/m16-2596
发表时间: 2017-07-18
影响因子: 39.2
作者:
Bergenstal, Richard M.;Gal, Robin L.;Beck, Roy W.
通讯作者: Beck, Roy W.
DOI: 10.1177/1932296815599177
发表时间: 2015-08-14
影响因子: 5
作者:
Fabris, Chiara;Patek, Stephen D;Breton, Marc D
通讯作者: Breton, Marc D
DOI: 10.1111/pedi.12067
发表时间: 2014-03-01
期刊: PEDIATRIC DIABETES
影响因子: 3.4
作者:
Campbell, Meredith S.;Schatz, Desmond A.;Haller, Michael J.
通讯作者: Haller, Michael J.
DOI: 10.2337/diabetes.49.11.1897
发表时间: 2000-11-01
期刊: DIABETES
影响因子: 7.7
作者:
Davis, SN;Mann, S;Costa, F
通讯作者: Costa, F
DOI: 10.1089/dia.2016.0146
发表时间: 2016-12-01
影响因子: 5.4
作者:
El-Laboudi, Ahmed H.;Godsland, Ian F.;Oliver, Nick S.
通讯作者: Oliver, Nick S.